AdvertisementA different kind of COVID vaccine is about ready to rollDecember 01, 2021Joe PalcafacebookEmailResearchers at the University of Washington Medicine Retrovirology Lab at Harborview Medical Center in Seattle process samples from Novavax's phase 3 COVID-19 vaccine clinical trial in February 2021. (Karen Ducey/Getty Images)
